Notch Therapeutics Funding: $85M Raised, Series A (2021)
Notch Therapeutics is based in Toronto, Canada. It has raised $85M in total funding. Latest round: Series A.
Notch Therapeutics funding overview
Notch Therapeutics is based in Toronto, Canada. Notch Therapeutics has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2021. The round record for Notch Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Baker Brothers Investments, Allogene Therapeutics, Lumira Ventures, CCRM Enterprises Holdings Ltd, Casdin Capital, Samsara BioCapital and 1 others. 7 distinct backers are named across the disclosed rounds.
Notch Therapeutics has raised $85M in total disclosed funding across the rounds on record.
Who has invested in Notch Therapeutics?
Baker Brothers Investments, Allogene Therapeutics, Lumira Ventures, CCRM Enterprises Holdings Ltd, Casdin Capital, Samsara BioCapital are named among the investors backing Notch Therapeutics.
What was the latest Notch Therapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2021.
Where is Notch Therapeutics based?
Notch Therapeutics is based in Toronto, Canada.
When did Notch Therapeutics last raise?
The last disclosed Notch Therapeutics round closed in February 2021 at Series A.
Notch Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Toronto below to benchmark round size and investor mix.
